Literature DB >> 16338761

Serotonin gene polymorphisms and bipolar I disorder: focus on the serotonin transporter.

Hader A Mansour1, Michael E Talkowski, Joel Wood, Lora Pless, Mikhil Bamne, Kodavali V Chowdari, Michael Allen, Charles L Bowden, Joseph Calabrese, Rif S El-Mallakh, Andrea Fagiolini, Stephen V Faraone, Mark D Fossey, Edward S Friedman, Laszlo Gyulai, Peter Hauser, Terence A Ketter, Jennifer M Loftis, Lauren B Marangell, David J Miklowitz, Andrew A Nierenberg, Jayendra Patel, Gary S Sachs, Pamela Sklar, Jordan W Smoller, Michael E Thase, Ellen Frank, David J Kupfer, Vishwajit L Nimgaonkar.   

Abstract

The pathogenesis of bipolar disorder may involve, at least in part, aberrations in serotonergic neurotransmission. Hence, serotonergic genes are attractive targets for association studies of bipolar disorder. We have reviewed the literature in this field. It is difficult to synthesize results as only one polymorphism per gene was typically investigated in relatively small samples. Nevertheless, suggestive associations are available for the 5HT2A receptor and the serotonin transporter genes. With the availability of extensive polymorphism data and high throughput genotyping techniques, comprehensive evaluation of these genes using adequately powered samples is warranted. We also report on our investigations of the serotonin transporter, SLC6A4 (17q11.1-q12). An insertion/deletion polymorphism (5HTTLPR) in the promoter region of this gene has been investigated intensively. However, the results have been inconsistent. We reasoned that other polymorphism/s may contribute to the associations and the inconsistencies may be due to variations in linkage disequilibrium (LD) patterns between samples. Therefore, we conducted LD analyses, as well as association and linkage using 12 polymorphisms, including 5HTTLPR. We evaluated two samples. The first sample consisted of 135 US Caucasian nuclear families having a proband with bipolar I disorder (BDI, DSM IV criteria) and available parents. For case-control analyses, the patients from these families were compared with cord blood samples from local Caucasian live births (n = 182). Our second, independent sample was recruited through the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD, 545 cases, 548 controls). No significant associations were detected at the individual polymorphism or haplotype level using the case-control or family-based analyses. Our analyses do not support association between SLC6A4 and BDI families. Further studies using sub-groups of BDI are worthwhile.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16338761     DOI: 10.1080/07853890500357428

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  14 in total

1.  Gender moderates the relationship between mania spectrum and serotonin transporter polymorphisms in depression.

Authors:  P Rucci; V L Nimgaonkar; H Mansour; M Miniati; I Masala; A Fagiolini; G B Cassano; E Frank
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-10-05       Impact factor: 3.568

2.  Using linkage information to weight a genome-wide association of bipolar disorder.

Authors:  D P Howrigan; N M Laird; J W Smoller; B Devlin; M B McQueen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-04-07       Impact factor: 3.568

3.  Fine-mapping reveals novel alternative splicing of the dopamine transporter.

Authors:  Michael E Talkowski; Kathleen L McCann; Michael Chen; Lora McClain; Mikhil Bamne; Joel Wood; Kodavali V Chowdari; Annie Watson; Konasale M Prasad; George Kirov; Lyudmilla Georgieva; Draga Toncheva; Hader Mansour; David A Lewis; Michael Owen; Michael O'Donovan; Panagiotis Papasaikas; Patrick Sullivan; Douglas Ruderfer; Jeffrey K Yao; Sherry Leonard; Pramod Thomas; Fabio Miyajima; John Quinn; A Javier Lopez; Vishwajit L Nimgaonkar
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-10-18       Impact factor: 3.568

4.  Clinical implications of genetic variation in the serotonin transporter promoter region: a review.

Authors:  Nicole S Luddington; Anitha Mandadapu; Margaret Husk; Rif S El-Mallakh
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

5.  Convergent patterns of association between phenylalanine hydroxylase variants and schizophrenia in four independent samples.

Authors:  Michael E Talkowski; Lora McClain; Trina Allen; L Dianne Bradford; Monica Calkins; Neil Edwards; Lyudmila Georgieva; Rodney Go; Ruben Gur; Raquel Gur; George Kirov; Kodavali Chowdari; Joseph Kwentus; Paul Lyons; Hader Mansour; Joseph McEvoy; Michael C O'Donovan; Judith O'Jile; Michael J Owen; Alberto Santos; Robert Savage; Draga Toncheva; Gerard Vockley; Joel Wood; Bernie Devlin; Vishwajit L Nimgaonkar
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-06-05       Impact factor: 3.568

6.  Dopaminergic gene polymorphisms and cognitive function in a north Indian schizophrenia cohort.

Authors:  Prachi Kukshal; Venkat Chowdari Kodavali; Vibhuti Srivastava; Joel Wood; Lora McClain; Triptish Bhatia; A M Bhagwat; Smita Neelkanth Deshpande; Vishwajit Laxmikant Nimgaonkar; B K Thelma
Journal:  J Psychiatr Res       Date:  2013-08-08       Impact factor: 4.791

7.  Whole-genome association study of bipolar disorder.

Authors:  P Sklar; J W Smoller; J Fan; M A R Ferreira; R H Perlis; K Chambert; V L Nimgaonkar; M B McQueen; S V Faraone; A Kirby; P I W de Bakker; M N Ogdie; M E Thase; G S Sachs; K Todd-Brown; S B Gabriel; C Sougnez; C Gates; B Blumenstiel; M Defelice; K G Ardlie; J Franklin; W J Muir; K A McGhee; D J MacIntyre; A McLean; M VanBeck; A McQuillin; N J Bass; M Robinson; J Lawrence; A Anjorin; D Curtis; E M Scolnick; M J Daly; D H Blackwood; H M Gurling; S M Purcell
Journal:  Mol Psychiatry       Date:  2008-03-04       Impact factor: 15.992

8.  A network of dopaminergic gene variations implicated as risk factors for schizophrenia.

Authors:  Michael E Talkowski; George Kirov; Mikhil Bamne; Lyudmila Georgieva; Gonzalo Torres; Hader Mansour; Kodavali V Chowdari; Vihra Milanova; Joel Wood; Lora McClain; Konasale Prasad; Brian Shirts; Jianping Zhang; Michael C O'Donovan; Michael J Owen; Bernie Devlin; Vishwajit L Nimgaonkar
Journal:  Hum Mol Genet       Date:  2007-11-27       Impact factor: 6.150

9.  Accurate, Large-Scale Genotyping of 5HTTLPR and Flanking Single Nucleotide Polymorphisms in an Association Study of Depression, Anxiety, and Personality Measures.

Authors:  Naomi R Wray; Michael R James; Scott D Gordon; Troy Dumenil; Leanne Ryan; William L Coventry; Dixie J Statham; Michele L Pergadia; Pamela A F Madden; Andrew C Heath; Grant W Montgomery; Nicholas G Martin
Journal:  Biol Psychiatry       Date:  2009-06-21       Impact factor: 13.382

10.  Linkage disequilibrium mapping of the chromosome 6q21-22.31 bipolar I disorder susceptibility locus.

Authors:  Jinbo Fan; Iuliana Ionita-Laza; Matthew B McQueen; Bernie Devlin; Shaun Purcell; Stephen V Faraone; Michael H Allen; Charles L Bowden; Joseph R Calabrese; Mark D Fossey; Edward S Friedman; Laszlo Gyulai; Peter Hauser; Terence B Ketter; Lauren B Marangell; David J Miklowitz; Andrew A Nierenberg; Jayendra K Patel; Gary S Sachs; Michael E Thase; Francine B Molay; Michael A Escamilla; Vishwajit L Nimgaonkar; Pamela Sklar; Nan M Laird; Jordan W Smoller
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-01-05       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.